Identification O +
of O +
a O +
novel O +
splice O +
site O +
mutation O +
of O +
CLCN5 B-Gene +
gene O +
and O +
characterization O +
of O +
a O +
new O +
alternative O +
5 O -
' O +
UTR O +
end O +
of O +
ClC-5 B-Gene +
mRNA O +
in O +
human O +
renal O +
tissue O +
and O +
leukocytes O -
. O +

Mutations O +
in O +
the O +
CLCN5 B-Gene +
gene O +
have O +
been O +
detected O +
in O +
Dent O -
's O +
disease O +
and O +
its O +
phenotypic O +
variants O +
( O -
X O -
- O -
linked O +
recessive O +
nephrolithiasis O -
, O +
X O -
- O -
linked O +
recessive O +
hypophosphatemic O +
rickets O -
, O +
and O +
idiopathic O +
low O -
- O -
molecular O -
- O -
weight O +
proteinuria O +
of O +
Japanese O +
children O -
) O -
. O +

Dent O -
's O +
disease O +
is O +
a O +
tubular O +
disorder O +
characterized O +
by O +
low O -
- O -
molecular O -
- O -
weight O +
proteinuria O -
, O +
and O +
nephrolithiasis O +
associated O +
with O +
nephrocalcinosis O +
and O +
hypercalciuria O -
. O +

ClC-5 B-Gene +
is O +
the O +
first O +
chloride O +
channel O +
for O +
which O +
a O +
definitive O +
role O +
in O +
the O +
trafficking O +
and O +
acidification O -
- O -
dependent O +
recycling O +
of O +
apical O +
membrane O +
proteins O +
has O +
been O +
established O -
. O +

In O +
the O +
course O +
of O +
CLCN5 B-Gene +
SSCP O +
analysis O +
in O +
patients O +
with O +
hypercalciuric O +
nephrolithiasis O -
, O +
we O +
detected O +
a O +
novel O +
mutation O +
at O +
intron O +
2 O +
of O +
the O +
CLCN5 B-Gene +
gene O -
, O +
a O +
T O -
- O -
to O -
- O -
G O +
substitution O -
, O +
located O +
17 O +
bp O +
upstream O +
of O +
the O +
AG O +
acceptor O +
siteCLCN5 O +
gene O -
, O +
a O +
T O -
- O -
to O -
- O -
G O +
substitution O -
, O +
located O +
17 O +
bp O +
upstream O +
of O +
the O +
AG O +
acceptor O +
site O -
. O +

To O +
determine O +
the O +
effect O +
of O +
IVS2 O -
- O -
17 O +
T O -
> O -
G O +
mutation O +
on O +
the O +
correct O +
splicing O +
of O +
intron O +
2 O -
, O +
we O +
studied O +
ClC-5 B-Gene +
transcripts O +
in O +
a O +
patient O -
's O +
peripheral O +
blood O +
leukocytes O +
by O +
means O +
of O +
quantitative O +
comparative O +
RT O -
/ O -
PCR O -
, O +
and O +
found O +
a O +
new O +
ClC-5 B-Gene +
5 O -
' O +
UTR O +
isoform O +
characterized O +
by O +
the O +
untranslated O +
exon O +
1b O +
and O +
by O +
retention O +
of O +
intron O +
1b O -
. O +

This O +
new O +
isoform O -
-- O -
isoform O +
B1 O -
- O -
-was O +
not O +
correlated O +
with O +
mutation O +
since O +
it O +
was O +
detected O +
also O +
in O +
control O +
leukocytes O +
and O +
in O +
renal O +
tissues O +
of O +
kidney O +
donors O -
, O +
thus O +
confirming O +
its O +
physiological O +
role O -
. O +

By O +
RACE O +
analysis O +
we O +
determined O +
the O +
putative O +
transcriptional O +
start O +
site O +
which O +
is O +
located O +
at O +
intron O +
1a O -
, O +
251 O +
nt O +
upstream O +
of O +
the O +
first O +
nucleotide O +
of O +
the O +
untranslated O +
exon O +
1b O -
. O +

ORF O +
analysis O +
revealed O +
that O +
intron O +
1b O +
retention O +
in O +
isoform O +
B1 O +
stabilizes O +
the O +
initiation O +
of O +
translation O +
to O +
the O +
AGT O +
at O +
position O +
297 O +
of O +
the O +
ClC-5 B-Gene +
cDNA O +
coding O +
region O -
. O +

TNXB B-Gene +
locus O +
may O +
be O +
a O +
candidate O +
gene O +
predisposing O +
to O +
schizophrenia O -
. O +

We O +
report O +
here O +
on O +
the O +
detection O +
of O +
nine O +
single O +
nucleotide O +
polymorphisms O +
( O -
SNPs O -
) O +
near O +
to O +
the O +
NOTCH4 B-Gene +
locus O +
in O +
the O +
search O +
for O +
schizophrenia O +
susceptibility O +
genes O +
in O +
the O +
class O +
III O +
region O +
of O +
the O +
human O +
major O +
histocompatibility O +
complex O +
( O -
MHC O -
) O -
. O +

We O +
totally O +
analyzed O +
122 O +
family O +
trios O +
recruited O +
in O +
the O +
UK O -
. O +

The O +
TDT O +
analysis O +
demonstrated O +
that O +
of O +
the O +
nine O +
SNPs O -
, O +
three O +
were O +
associated O +
with O +
schizophrenia O -
, O +
including O +
rs1009382 O +
( O -
P O +
= O +
0.00047 O -
) O -
, O +
rs204887 O +
( O -
P O +
= O +
0.007 O -
) O -
, O +
and O +
rs8283 O +
( O -
P O +
= O +
0.015 O -
) O -
. O +

Both O +
rs1009382 O +
and O +
rs204887 O +
are O +
present O +
in O +
the O +
TNXB B-Gene +
locus O -
. O +

The O +
rs1009382 O +
is O +
a O +
non O -
- O -
synonymous O +
SNP O +
located O +
in O +
exon O +
23 O +
of O +
the O +
gene O +
and O +
its O +
A O +
to O +
G O +
base O +
change O +
causes O +
a O +
Glu2578Gly O +
substitution O -
. O +

The O +
goodness O -
- O -
of O -
- O -
fit O +
test O +
showed O +
that O +
genotypic O +
distribution O +
of O +
rs1009382 O +
was O +
deviated O +
from O +
Hardy O -
- O -
Weinberg O +
equilibrium O +
due O +
to O +
homozygote O +
excess O +
in O +
the O +
patient O +
group O +
( O -
P O +
= O +
0.01 O -
) O -
, O +
suggesting O +
that O +
a O +
double O +
dose O +
of O +
a O +
genetic O +
risk O +
may O +
be O +
involved O -
. O +

Possibly O -
, O +
rs1009382 O +
is O +
a O +
candidate O +
SNP O +
predisposing O +
to O +
a O +
schizophrenic O +
illness O -
. O +

Moreover O -
, O +
the O +
test O +
for O +
linkage O +
disequilibrium O +
( O -
LD O -
) O +
between O +
paired O +
SNPs O +
showed O +
that O +
the O +
nine O +
SNPs O +
studied O +
may O +
be O +
in O +
the O +
same O +
LD O +
block O +
with O +
an O +
unexpected O +
pattern O +
as O +
the O +
strength O +
of O +
LD O +
was O +
not O +
correlated O +
with O +
the O +
distance O +
between O +
paired O +
SNPs O -
. O +

The O +
haplotype O +
analysis O +
suggested O +
that O +
there O +
might O +
be O +
more O +
than O +
one O +
disease O -
- O -
related O +
allele O +
located O +
in O +
the O +
class O +
III O +
region O +
of O +
the O +
MHC O -
, O +
and O +
that O +
these O +
alleles O +
possibly O +
confer O +
either O +
susceptibility O +
or O +
resistance O +
to O +
schizophrenia O -
. O +

No O +
association O +
between O +
the O +
APOE B-Gene +
gene O +
and O +
autism O -
. O +

Autism O +
is O +
a O +
neurodevelopmental O +
disorder O +
characterized O +
by O +
stereotypic O +
and O +
repetitive O +
behavior O +
and O +
interests O -
, O +
together O +
with O +
social O +
and O +
communicative O +
deficiencies O -
. O +

The O +
results O +
of O +
several O +
genomic O +
screens O +
suggest O +
the O +
presence O +
of O +
an O +
autism O +
susceptibility O +
locus O +
on O +
chromosome O +
19p13.2-q13.4 O -
. O +

The O +
apolipoprotein B-Gene +
E I-Gene +
( O -
APOE B-Gene -
) O +
gene O +
on O +
chromosome O +
19 O +
encodes O +
for O +
a O +
protein O -
, O +
apoE B-Gene -
, O +
whose O +
different O +
isoforms O +
( O -
E2 O -
, O +
E3 O -
, O +
E4 O -
) O +
influence O +
neuronal O +
growth O -
. O +

APOE B-Gene +
participates O +
in O +
lipid O +
transport O +
and O +
metabolism O -
, O +
repair O -
, O +
growth O -
, O +
and O +
maintenance O +
of O +
axons O +
and O +
myelin O +
during O +
neuronal O +
development O -
. O +

The O +
APOE B-Gene +
protein O +
competes O +
with O +
the O +
Reelin B-Gene +
protein O +
for O +
VLDL O -
/ O -
APOER2 B-Gene +
receptor O +
binding O -
. O +

Several O +
studies O +
have O +
reported O +
evidence O +
for O +
an O +
association O +
between O +
autism O +
and O +
the O +
Reelin B-Gene +
gene O -
. O +

Based O +
on O +
these O +
data O +
we O +
tested O +
for O +
association O +
between O +
APOE B-Gene +
and O +
autism O +
using O +
family O -
- O -
based O +
association O +
methods O +
in O +
a O +
data O +
set O +
of O +
322 O +
autism O +
families O -
. O +

Three O +
promoter O -
, O +
one O +
intronic O -
, O +
and O +
one O +
3 O -
' O +
UTR O +
single O +
nucleotide O +
polymorphisms O +
( O -
SNPs O -
) O +
in O +
the O +
APOE B-Gene +
gene O +
( O -
-491a O -
/ O -
t O -
, O +
-427c O -
/ O -
t O -
, O +
-219g O -
/ O -
t O -
, O +
113c O -
/ O -
g O -
, O +
and O +
5361c O -
/ O -
t O -
) O +
as O +
well O +
as O +
the O +
APOE B-Gene +
functional O +
polymorphism O +
( O -
E2 O -
, O +
E3 O -
, O +
E4 O -
) O +
were O +
examined O +
and O +
failed O +
to O +
reveal O +
significant O +
evidence O +
that O +
autism O +
is O +
associated O +
with O +
APOE B-Gene -
. O +

Polymorphisms O +
in O +
the O +
prion B-Gene +
protein I-Gene +
gene O +
and O +
in O +
the O +
doppel B-Gene +
gene I-Gene +
increase O +
susceptibility O +
for O +
Creutzfeldt O -
- O -
Jakob O +
disease O -
. O +

The O +
prion B-Gene +
protein I-Gene +
gene O +
( O -
PRNP B-Gene -
) O +
plays O +
a O +
central O +
role O +
in O +
the O +
origin O +
of O +
Creutzfeldt O -
- O -
Jakob O +
disease O +
( O -
CJD O -
) O -
, O +
but O +
there O +
is O +
growing O +
interest O +
in O +
other O +
polymorphisms O +
that O +
may O +
be O +
involved O +
in O +
CJD O -
. O +

Polymorphisms O +
upstream O +
of O +
PRNP B-Gene +
that O +
may O +
modulate O +
the O +
prion B-Gene +
protein I-Gene +
production O +
as O +
well O +
as O +
polymorphisms O +
in O +
the O +
prion B-Gene -
- I-Gene -
like I-Gene +
doppel I-Gene +
gene O +
( O -
PRND B-Gene -
) O +
have O +
been O +
studied O -
, O +
with O +
inconsistent O +
findings O -
. O +

We O +
investigated O +
the O +
role O +
of O +
a O +
single O -
- O -
nucleotide O +
polymorphism O +
( O -
SNP O +
1368 O -
) O +
located O +
upstream O +
of O +
PRNP O +
and O +
three O +
polymorphisms O +
in O +
PRND B-Gene +
( O -
T26 O -
M O -
, O +
P56L O +
and O +
T174 O -
M O -
) O +
in O +
CJD O -
. O +

The O +
study O +
included O +
a O +
population O -
- O -
based O +
sample O +
of O +
52 O +
patients O +
with O +
sporadic O +
CJD O +
and O +
250 O +
controls O -
. O +

We O +
analysed O +
our O +
data O +
as O +
single O +
markers O +
and O +
haplotypes O -
. O +

Further O -
, O +
we O +
conducted O +
a O +
meta O -
- O -
analysis O +
on O +
PRND B-Gene +
T174 O -
M O +
comparing O +
the O +
data O +
of O +
the O +
four O +
studies O +
conducted O +
to O +
date O -
. O +

For O +
SNP O +
1368 O +
and O +
PRNP B-Gene +
M129V O -
, O +
we O +
found O +
significant O +
evidence O +
for O +
linkage O +
disequilibrium O -
. O +

No O +
evidence O +
was O +
found O +
for O +
a O +
relation O +
of O +
SNP O +
1368 O +
to O +
CJD O +
independent O +
of O +
PRNP B-Gene +
M129V O -
. O +

We O +
further O +
found O +
a O +
significant O +
increased O +
prevalence O +
of O +
M O +
homozygotes O +
at O +
PRND B-Gene +
T174 O -
M O +
among O +
sporadic O +
CJD O +
patients O -
, O +
when O +
adjusting O +
the O +
analyses O +
for O +
the O +
other O +
genotypes O -
. O +

In O +
the O +
haplotype O +
analyses O -
, O +
the O +
association O +
was O +
strongest O +
for O +
persons O +
homozygous O +
for O +
PRNP B-Gene +
129 O -
M O +
and O +
PRND B-Gene +
174 O -
M O +
( O -
odds O +
ratio O +
4.35 O -
, O +
95 O -
% O +
confidence O +
interval O +
1.05 O -
- O -
8.09 O -
; O +
P=0.04 O -
) O -
. O +

The O +
meta O -
- O -
analysis O +
on O +
the O +
PRND B-Gene +
T174 O -
M O +
polymorphism O +
did O +
not O +
show O +
a O +
consistent O +
effect O +
across O +
studies O -
, O +
raising O +
the O +
question O +
as O +
to O +
whether O +
PRND B-Gene +
174 O -
M O +
is O +
causally O +
related O +
to O +
CJD O -
, O +
or O +
whether O +
the O +
PRND B-Gene +
allele O +
is O +
in O +
linkage O +
disequilibrium O +
with O +
another O +
polymorphism O +
related O +
to O +
CJD O -
. O +

Is O +
there O +
a O +
future O +
for O +
TNF B-Gene +
promoter O +
polymorphisms O -
? O +

The O +
in O +
vitro O +
study O +
of O +
TNF B-Gene +
promoter O +
polymorphism O +
( O -
SNP O -
) O +
function O +
was O +
stimulated O +
by O +
the O +
numerous O +
case O -
- O -
control O +
( O -
association O -
) O +
studies O +
of O +
the O +
polymorphisms O +
in O +
relation O +
to O +
human O +
disease O +
and O +
the O +
appearance O +
of O +
several O +
studies O +
claiming O +
to O +
show O +
a O +
functional O +
role O +
for O +
these O +
SNPs O +
provided O +
a O +
further O +
impetus O +
to O +
researchers O +
interested O +
in O +
the O +
role O +
of O +
TNF B-Gene +
in O +
their O +
disease O +
of O +
interest O -
. O +

In O +
this O +
review O +
we O +
consider O +
case O -
- O -
control O +
studies O -
, O +
concentrating O +
on O +
the O +
autoimmune O +
and O +
inflammatory O +
diseases O +
rheumatoid O +
arthritis O -
, O +
multiple O +
sclerosis O -
, O +
ankylosing O +
spondylitis O -
, O +
and O +
asthma O -
, O +
and O +
on O +
infectious O +
diseases O +
including O +
malaria O -
, O +
hepatitis O +
B O +
and O +
C O +
infection O -
, O +
leprosy O +
and O +
sepsis O -
/ O -
septic O +
shock O -
. O +

We O +
also O +
review O +
the O +
available O +
evidence O +
on O +
the O +
functional O +
role O +
of O +
the O +
various O +
TNF B-Gene +
promoter O +
polymorphisms O -
. O +

In O +
general O -
, O +
case O -
- O -
control O +
studies O +
have O +
produced O +
mixed O +
results O -
, O +
with O +
little O +
consensus O +
in O +
most O +
cases O +
on O +
whether O +
any O +
TNF B-Gene +
polymorphisms O +
are O +
actually O +
associated O +
with O +
disease O -
, O +
although O +
results O +
have O +
been O +
more O +
consistent O +
in O +
the O +
case O +
of O +
infectious O +
diseases O -
, O +
particularly O +
malaria O -
. O +

Functional O +
studies O +
have O +
also O +
produced O +
mixed O +
results O +
but O +
recent O +
work O +
suggests O +
that O +
the O +
much O +
studied O +
-308G O -
/ O -
A O +
polymorphism O +
is O +
not O +
functional O -
, O +
while O +
the O +
function O +
of O +
other O +
TNF B-Gene +
polymorphisms O +
remains O +
controversial O -
. O +

Studies O +
of O +
the O +
TNF B-Gene +
region O +
are O +
increasingly O +
using O +
extended O +
haplotypes O +
that O +
can O +
better O +
capture O +
the O +
variation O +
of O +
the O +
MHC O +
region O -
. O +

Association O +
of O +
the O +
homeobox O +
transcription O +
factor O -
, O +
ENGRAILED B-Gene +
2 I-Gene -
, I-Gene +
3 I-Gene -
, O +
with O +
autism O +
spectrum O +
disorder O -
. O +

Mouse O +
mutants O +
of O +
the O +
homeobox O +
transcription O +
factor O +
Engrailed2 B-Gene +
( O -
En2 B-Gene -
) O +
and O +
autistic O +
individuals O +
display O +
similar O +
cerebellar O +
morphological O +
abnormalities O -
, O +
which O +
include O +
hypoplasia O +
and O +
a O +
decrease O +
in O +
the O +
number O +
of O +
Purkinje O +
cells O -
. O +

Human O +
EN2 B-Gene +
maps O +
to O +
7q36 O -
, O +
a O +
chromosomal O +
region O +
that O +
has O +
demonstrated O +
suggestive O +
linkage O +
to O +
autism O +
spectrum O +
disorder O +
( O -
ASD O -
) O -
. O +

To O +
investigate O +
EN2 B-Gene +
for O +
evidence O +
of O +
association O +
with O +
ASD O -
, O +
four O +
single O -
- O -
nucleotide O +
polymorphisms O +
( O -
SNPs O -
) O +
( O -
rs3735653 O -
, O +
rs1861972 O -
, O +
rs1861973 O -
, O +
rs2361689 O -
) O +
that O +
span O +
the O +
majority O +
of O +
the O +
8.0 O +
kb O +
gene O +
were O +
assessed O +
by O +
the O +
transmission O -
/ O -
disequilibrium O +
test O -
. O +

Initially O -
, O +
138 O +
triads O +
of O +
autistic O +
individuals O +
and O +
their O +
parents O +
were O +
tested O -
. O +

Two O +
intronic O +
SNPs O +
( O -
rs1861972 O +
and O +
rs1861973 O -
) O +
demonstrated O +
significant O +
association O +
with O +
autism O +
( O -
rs1861972 O -
, O +
P=0.0018 O -
; O +
rs1861973 O -
, O +
P=0.0003 O -
; O +
haplotype O -
, O +
P=0.000005 O -
) O -
. O +

Flanking O +
exonic O +
SNPs O +
( O -
rs3735653 O +
and O +
rs2361689 O -
) O +
did O +
not O +
display O +
association O -
. O +

This O +
analysis O +
was O +
then O +
extended O +
to O +
include O +
167 O +
small O +
nuclear O +
ASD O +
pedigrees O +
and O +
significant O +
association O +
was O +
again O +
only O +
observed O +
for O +
rs1861972 O +
and O +
rs1861973 O +
under O +
both O +
the O +
narrow O +
and O +
broad O +
diagnostic O +
criteria O +
( O -
narrow O -
: O +
rs1861972 O +
P=0.0290 O -
, O +
rs1861973 O +
P=0.0073 O -
, O +
haplotype O +
P=0.0009 O -
; O +
broad O -
: O +
rs1861972 O +
P=0.0175 O -
, O +
rs1861973 O +
P=0.0107 O -
, O +
haplotype O +
P=0.0024 O -
) O -
. O +

These O +
data O +
demonstrate O +
association O +
between O +
a O +
cerebellar O +
patterning O +
gene O +
and O +
ASD O -
, O +
suggesting O +
a O +
role O +
for O +
EN2 B-Gene +
as O +
a O +
susceptibility O +
locus O +
and O +
supporting O +
a O +
neurodevelopmental O +
defect O +
hypothesis O +
in O +
the O +
etiology O +
of O +
autism O -
. O +

Binge O -
- O -
eating O +
episodes O +
are O +
not O +
characteristic O +
of O +
carriers O +
of O +
melanocortin-4 B-Gene +
receptor O +
gene O +
mutations O -
. O +

Recently O -
, O +
Branson O +
and O +
coworkers O +
reported O +
a O +
strong O +
association O +
between O +
binge O -
- O -
eating O +
disorder O +
( O -
BED O -
) O +
and O +
variants O +
in O +
the O +
melanocortin-4 B-Gene +
receptor O +
gene O +
( O -
MC4R B-Gene -
) O -
. O +

In O +
the O +
current O +
study O -
, O +
we O +
compared O +
the O +
eating O +
behavior O +
of O +
43 O +
obese O +
probands O +
with O +
functionally O +
relevant O +
MC4R B-Gene +
mutations O +
and O +
of O +
35 O +
polymorphism O +
carriers O +
( O -
V103I O +
or O +
I251L O -
) O +
with O +
wild O -
- O -
type O +
carriers O -
. O +

The O +
module O +
for O +
eating O +
disorders O +
of O +
the O +
Composite O +
International O +
Diagnostic O +
Interview O +
was O +
used O +
to O +
identify O +
binge O -
- O -
eating O +
behavior O -
. O +

The O +
Three O -
- O -
Factor O +
Eating O +
Questionnaire O +
and O +
the O +
Leeds O +
Food O +
Frequency O +
Questionnaire O +
were O +
used O +
to O +
assess O +
restrained O +
eating O -
, O +
disinhibition O -
, O +
hunger O +
and O +
percent O +
total O +
energy O +
intake O +
as O +
fat O -
. O +

No O +
significant O +
differences O +
between O +
carriers O +
of O +
MC4R B-Gene +
variants O +
and O +
wild O -
- O -
type O +
carriers O +
were O +
detected O -
. O +

In O +
particular O -
, O +
we O +
found O +
no O +
evidence O +
for O +
an O +
increased O +
rate O +
of O +
binge O -
- O -
eating O +
behavior O +
in O +
obese O +
carriers O +
of O +
MC4R B-Gene +
variants O -
. O +

Our O +
findings O +
do O +
not O +
support O +
the O +
strong O +
association O +
between O +
BED O +
and O +
MC4R B-Gene +
carrier O +
status O -
. O +

A O +
functional O +
haplotype O +
of O +
the O +
PADI4 B-Gene +
gene O +
associated O +
with O +
rheumatoid O +
arthritis O +
in O +
a O +
Japanese O +
population O +
is O +
not O +
associated O +
in O +
a O +
United O +
Kingdom O +
population O -
. O +

OBJECTIVE O -
: O +
In O +
the O +
era O +
of O +
postgenomic O +
research O -
, O +
linkage- O +
and O +
association O -
- O -
based O +
strategies O +
are O +
beginning O +
to O +
reveal O +
novel O +
complex O +
disease O +
genes O -
. O +

Using O +
such O +
an O +
approach O -
, O +
a O +
functional O +
haplotype O +
of O +
the O +
peptidylarginine B-Gene +
deiminase I-Gene +
4 I-Gene +
gene O +
( O -
PADI4 B-Gene -
) O +
has O +
recently O +
been O +
identified O +
as O +
a O +
gene O +
conferring O +
susceptibility O +
to O +
rheumatoid O +
arthritis O +
( O -
RA O -
) O +
in O +
a O +
Japanese O +
population O -
. O +

In O +
the O +
present O +
study O -
, O +
we O +
investigated O +
the O +
association O +
of O +
single O -
- O -
nucleotide O +
polymorphisms O +
( O -
SNPs O -
) O +
in O +
the O +
PADI4 B-Gene +
gene O +
with O +
RA O +
in O +
a O +
UK O +
population O -
. O +

METHODS O -
: O +
Association O +
with O +
4 O +
exonic O +
SNPs O +
( O -
padi4_89*G B-Gene -
/ O -
A O -
, O +
padi4_90*T B-Gene -
/ O -
C O -
, O +
padi4_92*G B-Gene -
/ O -
C O -
, O +
and O +
padi4_104*T B-Gene -
/ O -
C O -
) O -
, O +
mapping O +
to O +
the O +
PADI4 B-Gene +
gene O +
and O +
defining O +
a O +
haplotype O +
previously O +
reported O +
to O +
be O +
associated O +
with O +
RA O -
, O +
was O +
investigated O -
. O +

Genotyping O +
was O +
performed O +
using O +
5 O -
' O +
allelic O +
discrimination O +
assays O -
. O +

Estimated O +
haplotypes O +
were O +
generated O +
using O +
the O +
expectation O -
- O -
maximization O +
algorithm O -
, O +
and O +
frequencies O +
of O +
the O +
SNPs O +
and O +
haplotypes O +
were O +
compared O +
between O +
unrelated O +
Caucasian O +
RA O +
patients O +
from O +
the O +
UK O +
( O -
n O +
= O +
839 O -
) O +
and O +
population O +
controls O +
( O -
n O +
= O +
481 O -
) O -
. O +

RESULTS O -
: O +
Allele O +
frequencies O +
for O +
the O +
4 O +
SNPs O +
in O +
the O +
UK O +
population O +
were O +
similar O +
to O +
those O +
reported O +
in O +
the O +
Japanese O +
control O +
population O -
, O +
but O +
none O +
of O +
these O +
was O +
associated O +
with O +
RA O -
. O +

As O +
in O +
the O +
Japanese O +
population O -
, O +
the O +
SNPs O +
in O +
the O +
UK O +
population O +
defined O +
2 O +
major O +
haplotypes O -
, O +
but O +
neither O +
was O +
associated O +
with O +
RA O +
( O -
P O +
= O +
0.79 O -
) O -
. O +

CONCLUSION O -
: O +
A O +
PADI4 B-Gene +
susceptibility O +
haplotype O +
associated O +
with O +
RA O +
in O +
a O +
Japanese O +
population O +
is O +
not O +
associated O +
with O +
RA O +
in O +
a O +
UK O +
population O -
. O +

Other O +
genes O +
involved O +
in O +
the O +
citrullinating O +
pathway O +
remain O +
strong O +
candidate O +
RA O -
- O -
susceptibility O +
genes O +
and O +
require O +
further O +
investigation O -
. O +

Extended O +
linkage O +
disequilibrium O +
surrounding O +
the O +
hemoglobin B-Gene +
E I-Gene +
variant O +
due O +
to O +
malarial O +
selection O -
. O +

The O +
hemoglobin B-Gene +
E I-Gene +
variant O +
( O -
HbE B-Gene -
; O +
( O +
beta O +
) O -
26Glu-->Lys O -
) O +
is O +
concentrated O +
in O +
parts O +
of O +
Southeast O +
Asia O +
where O +
malaria O +
is O +
endemic O -
, O +
and O +
HbE B-Gene +
carrier O +
status O +
has O +
been O +
shown O +
to O +
confer O +
some O +
protection O +
against O +
Plasmodium O +
falciparum O +
malaria O -
. O +

To O +
examine O +
the O +
effect O +
of O +
natural O +
selection O +
on O +
the O +
pattern O +
of O +
linkage O +
disequilibrium O +
( O -
LD O -
) O +
and O +
to O +
infer O +
the O +
evolutionary O +
history O +
of O +
the O +
HbE B-Gene +
variant O -
, O +
we O +
analyzed O +
biallelic O +
markers O +
surrounding O +
the O +
HbE B-Gene +
variant O +
in O +
a O +
Thai O +
population O -
. O +

Pairwise O +
LD O +
analysis O +
of O +
HbE B-Gene +
and O +
43 O +
surrounding O +
biallelic O +
markers O +
revealed O +
LD O +
of O +
HbE B-Gene +
extending O +
beyond O +
100 O +
kb O -
, O +
whereas O +
no O +
LD O +
was O +
observed O +
between O +
non O -
- O -
HbE B-Gene +
variants O +
and O +
the O +
same O +
markers O -
. O +

The O +
inferred O +
haplotype O +
network O +
suggests O +
a O +
single O +
origin O +
of O +
the O +
HbE B-Gene +
variant O +
in O +
the O +
Thai O +
population O -
. O +

Forward O -
- O -
in O -
- O -
time O +
computer O +
simulations O +
under O +
a O +
variety O +
of O +
selection O +
models O +
indicate O +
that O +
the O +
HbE B-Gene +
variant O +
arose O +
1,240 O -
- O -
4,440 O +
years O +
ago O -
. O +

These O +
results O +
support O +
the O +
conjecture O +
that O +
the O +
HbE B-Gene +
mutation O +
occurred O +
recently O -
, O +
and O +
the O +
allele O +
frequency O +
has O +
increased O +
rapidly O -
. O +

Our O +
study O +
provides O +
another O +
clear O +
demonstration O +
that O +
a O +
high O -
- O -
resolution O +
LD O +
map O +
across O +
the O +
human O +
genome O +
can O +
detect O +
recent O +
variants O +
that O +
have O +
been O +
subjected O +
to O +
positive O +
selection O -
. O +

Pharmacogenetics O +
of O +
the O +
CD14 B-Gene +
endotoxin O +
receptor O +
polymorphism O +
and O +
progression O +
of O +
coronary O +
atherosclerosis O -
. O +

Atherosclerosis O +
is O +
at O +
least O +
in O +
part O +
an O +
inflammatory O +
disease O -
. O +

CD14 B-Gene +
is O +
an O +
endotoxin O +
receptor O +
that O +
after O +
binding O +
of O +
lipopolysaccharides O +
evokes O +
endothelial O +
activation O +
and O +
secretion O +
of O +
several O +
cytokines O -
. O +

A O +
polymorphism O +
of O +
CD14 B-Gene +
has O +
been O +
associated O +
with O +
myocardial O +
infarction O -
. O +

We O +
evaluated O +
the O +
role O +
of O +
the O +
-159 O +
T O -
/ O -
C O +
polymorphism O +
in O +
the O +
promoter O +
region O +
of O +
the O +
CD14 B-Gene +
gene O +
in O +
relation O +
to O +
severity O +
and O +
progression O +
of O +
coronary O +
atherosclerosis O +
and O +
response O +
to O +
the O +
HMG B-Gene +
CoA I-Gene +
reductase I-Gene +
inhibitor O +
pravastatin O -
. O +

We O +
recruited O +
patients O +
from O +
the O +
multi O -
- O -
center O +
double O -
- O -
blind O +
randomized O +
placebo O +
controlled O +
REGRESS O +
trial O +
and O +
genotyped O +
the O +
-159T O -
/ O -
C O +
CD14 B-Gene +
polymorphism O -
. O +

DNA O +
and O +
angiographic O +
follow O -
- O -
up O +
were O +
available O +
from O +
759 O +
patients O +
with O +
objectivated O +
coronary O +
artery O +
disease O -
. O +

We O +
measured O +
changes O +
in O +
mean O +
segment O +
diameter O +
( O -
MSD O -
) O +
and O +
minimum O +
obstruction O +
diameter O +
( O -
MOD O -
) O +
with O +
quantitative O +
coronary O +
angiography O +
and O +
noted O +
the O +
occurrence O +
of O +
major O +
adverse O +
cardiac O +
events O -
. O +

The O +
genotype O +
distribution O +
was O +
28 O -
% O +
TT O -
, O +
49 O -
% O +
CT O -
, O +
23 O -
% O +
CC O -
. O +

We O +
did O +
not O +
find O +
any O +
association O +
between O +
genotype O +
and O +
MSD O +
and O +
MOD O +
at O +
baseline O -
, O +
frequency O +
of O +
previous O +
myocardial O +
infarction O -
, O +
changes O +
in O +
MSD O +
and O +
MOD O +
or O +
major O +
clinical O +
events O -
. O +

Treatment O +
with O +
the O +
HMG B-Gene +
CoA I-Gene +
reductase I-Gene +
inhibitor O +
pravastatin O +
reduced O +
progression O +
of O +
coronary O +
atherosclerosis O +
and O +
adverse O +
events O +
equally O +
for O +
all O +
genotypes O -
. O +

We O +
conclude O -
, O +
that O +
the O +
-159T O -
/ O -
C O +
polymorphism O +
in O +
the O +
CD14 B-Gene +
monocyte O +
receptor O +
gene O +
was O +
not O +
associated O +
with O +
progression O +
of O +
coronary O +
atherosclerosis O +
in O +
this O +
population O +
nor O +
did O +
it O +
influence O +
the O +
efficacy O +
of O +
pravastatin O +
in O +
the O +
treatment O +
of O +
atherosclerosis O -
. O +

Evidence O +
for O +
CTLA4 B-Gene +
as O +
a O +
susceptibility O +
gene O +
for O +
systemic O +
lupus O +
erythematosus O -
. O +

Several O +
lines O +
of O +
evidence O +
implicate O +
the O +
Cytotoxic B-Gene +
T I-Gene +
Lymphocyte I-Gene +
Antigen I-Gene +
4 I-Gene +
( O -
CTLA4 B-Gene -
) O +
gene O +
in O +
susceptibility O +
to O +
autoimmune O +
disease O -
. O +

We O +
have O +
examined O +
the O +
association O +
of O +
systemic O +
lupus O +
erythematosus O +
( O -
SLE O -
) O +
with O +
polymorhisms O +
within O +
the O +
CTLA4 B-Gene +
gene O +
that O +
were O +
previously O +
proposed O +
to O +
regulate O +
CTLA-4 B-Gene +
function O -
: O +
a O +
single O +
nucleotide O +
polymorphism O +
( O -
SNP O -
) O +
in O +
position O +
+ O -
49 O +
of O +
exon O +
1 O +
and O +
a O +
dinucleotide O +
repeat O +
in O +
the O +
3 O -
' O +
untranslated O +
region O +
( O -
3'UTR O -
) O -
. O +

The O +
3'UTR O +
repeat O +
showed O +
a O +
significant O +
association O +
with O +
SLE O -
, O +
with O +
one O +
allele O +
conferring O +
susceptibility O +
and O +
another O +
conferring O +
protection O +
to O +
the O +
disease O -
. O +

The O +
associated O +
alleles O +
do O +
not O +
support O +
previous O +
suggestions O +
of O +
an O +
allele O +
size O -
- O -
dependent O +
effect O +
of O +
the O +
3 O -
' O +
UTR O +
polymorphism O +
in O +
autoimmunity O +
development O +
and O +
instead O +
suggest O +
that O +
it O +
is O +
in O +
linkage O +
disequilibrium O +
with O +
a O +
true O +
causative O +
locus O -
. O +

No O +
association O +
of O +
the O +
exon O +
1 O +
SNP O +
with O +
SLE O +
was O +
found O +
in O +
our O +
population O -
. O +

Given O +
the O +
conflicting O +
results O +
obtained O +
in O +
different O +
studies O +
on O +
the O +
association O +
of O +
SLE O +
with O +
this O +
polymorphism O -
, O +
we O +
performed O +
a O +
meta O -
- O -
analysis O +
including O +
seven O +
previously O +
published O +
studies O +
and O +
the O +
present O +
one O -
. O +

Significantly O +
increased O +
and O +
decreased O +
risks O +
for O +
SLE O +
were O +
found O +
for O +
carriers O +
of O +
the O +
G O +
allele O +
and O +
the O +
A O +
allele O -
, O +
respectively O -
. O +

The O +
functional O +
characterization O +
of O +
disease O -
- O -
associated O +
CTLA4 B-Gene +
gene O +
variants O +
is O +
now O +
required O +
to O +
elucidate O +
their O +
role O +
in O +
the O +
pathogenesis O +
of O +
SLE O +
and O +
other O +
autoimmune O +
diseases O -
. O +

